2. Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release. Tasaka K, Mio M, Izushi K, Akagi M, Makino T. Agents Actions. 1988;23(3-4):157–160.
3. Effectiveness of Dp2 nasal therapy for Dp2- induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator. Liu YH, Tsai CF, Kao MC, Lai YL, Tsai JJ. J Microbiol Immunol Infect. 2003;36(4):236–242.
4. The use of Ganoderma lucidum (Reishi) in the management of Histamine-mediated allergic responses. Powell M. Nutritional Practitioner Magazine. 2004:26–30.
5. Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis. Mizutani N, Nabe T, Shimazu M, Yoshino S, Kohno S. Phytother Res. 2012;26(3):325–332.
6. Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum. Bhardwaj N, Katyal P, Sharma AK. Recent Pat Inflamm Allergy Drug Discov. 2014;8(2):104–117.
7. Chen, M.L., B.F.Lin. 2007b. Effects of triterpenoid-rich extracts of Ganoderma tsugae on airway hyperreactivity and Th2 responses in vivo. International Archives of Allergy and Immunology, 143(1):21-30.